Efficacy of Bimatoprost in Treating Chemotherapy-Induced Milphosis: A Comprehensive Review of Randomized Controlled Trials

This review assesses the effectiveness of bimatoprost in treating chemotherapy-induced milphosis, focusing on three randomized controlled trials with 186 participants. Bimatoprost significantly improved eyelash length, thickness, and pigmentation, enhancing patient satisfaction. Although the treatment showed promise, limitations such as small sample sizes and short follow-up periods highlight the need for further research. Bimatoprost has a favorable safety profile, with mild adverse events reported, and may be considered by dermatologists and oncologists as part of supportive care for nonscalp alopecia in oncology patients.